NO20022276D0 - Human neurokinin-B-forlöper fra placenta - Google Patents

Human neurokinin-B-forlöper fra placenta

Info

Publication number
NO20022276D0
NO20022276D0 NO20022276A NO20022276A NO20022276D0 NO 20022276 D0 NO20022276 D0 NO 20022276D0 NO 20022276 A NO20022276 A NO 20022276A NO 20022276 A NO20022276 A NO 20022276A NO 20022276 D0 NO20022276 D0 NO 20022276D0
Authority
NO
Norway
Prior art keywords
precursor
placenta
methods
human neurokinin
neurokinin
Prior art date
Application number
NO20022276A
Other languages
English (en)
Other versions
NO330412B1 (no
NO20022276L (no
Inventor
Nigel Page
Phillip Lowery
Original Assignee
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Reading filed Critical Univ Reading
Publication of NO20022276D0 publication Critical patent/NO20022276D0/no
Publication of NO20022276L publication Critical patent/NO20022276L/no
Publication of NO330412B1 publication Critical patent/NO330412B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20022276A 1999-11-16 2002-05-14 Fremgangsmate for forutsigelse eller diagnostisering av graviditetsindusert hypertension, diagnostisk sett, og anvendelse av middel som hemmer biologisk effekt av neurokinin B NO330412B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9927125.6A GB9927125D0 (en) 1999-11-16 1999-11-16 Placental human neurokinin B precursor
PCT/GB2000/004315 WO2001036979A2 (en) 1999-11-16 2000-11-10 Placental human neurokinin b precursor

Publications (3)

Publication Number Publication Date
NO20022276D0 true NO20022276D0 (no) 2002-05-14
NO20022276L NO20022276L (no) 2002-07-05
NO330412B1 NO330412B1 (no) 2011-04-11

Family

ID=10864633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022276A NO330412B1 (no) 1999-11-16 2002-05-14 Fremgangsmate for forutsigelse eller diagnostisering av graviditetsindusert hypertension, diagnostisk sett, og anvendelse av middel som hemmer biologisk effekt av neurokinin B

Country Status (15)

Country Link
US (1) US7947458B1 (no)
EP (1) EP1229965B1 (no)
JP (1) JP4668501B2 (no)
CN (1) CN1414871A (no)
AT (1) ATE299739T1 (no)
AU (1) AU778423B2 (no)
CA (1) CA2391531A1 (no)
DE (1) DE60021409T2 (no)
ES (1) ES2244480T3 (no)
GB (1) GB9927125D0 (no)
IL (1) IL149598A0 (no)
NO (1) NO330412B1 (no)
NZ (1) NZ519283A (no)
WO (1) WO2001036979A2 (no)
ZA (1) ZA200203880B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919433B2 (en) 1997-03-14 2005-07-19 Human Genome Sciences, Inc. Antibodies to protein HPMBQ91
EP1333092A3 (en) * 1997-03-14 2003-12-10 Human Genome Sciences, Inc. 28 human secreted proteins
WO2023278843A2 (en) 2021-07-02 2023-01-05 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742156A (en) 1985-09-30 1988-05-03 Mcneilab, Inc. Peptide antagonists of neurokinin B and opthalmic solutions containing them
US4665157A (en) 1985-09-30 1987-05-12 Mcneilab, Inc. Peptide antagonists of neurokinin B
US5331089A (en) 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
WO1994004494A1 (en) 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists
EP1082959A1 (en) 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
US5328927A (en) 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
US5612336A (en) 1992-07-13 1997-03-18 Merck, Sharp & Dohme Ltd. Heterocyclic amide derivatives as tachykinin antagonists
US5922681A (en) * 1992-09-14 1999-07-13 Warner-Lambert Company Endothelin antagonists
FR2696178B1 (fr) 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5344830A (en) 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
US5491140A (en) 1994-06-30 1996-02-13 Eli Lilly And Company Naphthyl tachykinin receptor antagonists to treat physiological conditions
BR9508375A (pt) 1994-07-12 1997-10-28 Lilly Co Eli Antagonista de receptor de taquicinina heterociclica
CA2154116A1 (en) 1994-07-22 1996-01-23 Philip Arthur Hipskind 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists
JP2000511193A (ja) * 1996-05-24 2000-08-29 イーライ・リリー・アンド・カンパニー 高血圧の処置法
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US5846973A (en) 1997-05-23 1998-12-08 Eli Lilly And Company Methods of treating pulmonary hypertension
US5985606A (en) 1997-06-19 1999-11-16 Incyte Pharmaceuticals, Inc. Human preprotachykinin B
CA2236489A1 (en) * 1997-07-14 1999-01-14 Human Genome Sciences Novel compounds
EP0892053A3 (en) * 1997-07-14 1999-12-29 Smithkline Beecham Plc production of recombinant HPMBQ91 polypeptide and uses thereof
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone

Also Published As

Publication number Publication date
ES2244480T3 (es) 2005-12-16
US7947458B1 (en) 2011-05-24
CN1414871A (zh) 2003-04-30
AU1289801A (en) 2001-05-30
EP1229965B1 (en) 2005-07-20
DE60021409T2 (de) 2006-05-24
AU778423B2 (en) 2004-12-02
GB9927125D0 (en) 2000-01-12
NO330412B1 (no) 2011-04-11
EP1229965A2 (en) 2002-08-14
NO20022276L (no) 2002-07-05
JP4668501B2 (ja) 2011-04-13
WO2001036979A2 (en) 2001-05-25
WO2001036979A3 (en) 2002-05-02
CA2391531A1 (en) 2001-05-25
IL149598A0 (en) 2002-11-10
ATE299739T1 (de) 2005-08-15
DE60021409D1 (de) 2005-08-25
ZA200203880B (en) 2003-08-15
JP2003515138A (ja) 2003-04-22
NZ519283A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
IL156618A0 (en) Crystals of whole antibodies and fragments thereof, methods for the preparation thereof and diagnostic kits utilizing the same
ATE364618T1 (de) Antikörper gegen das muc18-antigen
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
CY1112507T1 (el) Μορια αντισωματος που εχουν ειδικοτητα για την ανθρωπινη ιl-1β
ATE197592T1 (de) Monoklonaler antikörper gegen cd44v6
DE60130538D1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
DE3750389D1 (de) Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren.
TR200002284T2 (tr) Mage ailesinden tümör ile ilgili tümör türevleri
BRPI9912227B1 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
ECSP088636A (es) Antígenos de ácido des-n-acetil-siálico, anticuerpos para los mismos, y métodos de uso en la terapia de cáncer
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
HUP0400697A2 (hu) Elcsendesített anti-CD28 ellenanyagok és használatuk
DE69938725D1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
NO20022276D0 (no) Human neurokinin-B-forlöper fra placenta
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2004032599A3 (en) Novel immunogenic proteins of leptospira
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
ITRM20040098A1 (it) Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
PT1196188E (pt) Anticorpos monoclonais selectivos para o fcv e sua utilizacao para o tratamento de doencas associadas ao fcv
DE69615537T2 (de) Helicobacter pylori antigen
ATE343596T1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees